Exploring Type 1.5 Diabetes: Awareness and Diagnosis Challenges

Type 1.5 diabetes, also known as latent autoimmune diabetes in adults (LADA), shares traits with both type 1 and type 2 diabetes. This condition is often misdiagnosed, leading to delayed treatments. Recent awareness has increased following Lance Bass's diagnosis. Proper diagnosis and treatment are critical to avoid health complications.

Type 1.5 diabetes, also known as latent autoimmune diabetes in adults (LADA), is a condition that exhibits characteristics of both type 1 and type 2 diabetes. Recently, the condition gained attention when Lance Bass, a member of the renowned American pop band NSYNC, disclosed his diagnosis.

Unlike type 1, where there is an immediate need for insulin due to autoimmune destruction of pancreatic cells, type 1.5 diabetes progresses more slowly. Many patients manage their condition initially with oral medications but typically require insulin within five years.

Despite its rising recognition, type 1.5 diabetes remains under-researched and frequently misdiagnosed as type 2 diabetes. Accurate identification necessitates specialized blood tests, which are not always routine. Proper and timely diagnosis is essential for effective treatment and avoiding complications associated with improper disease management.

(With inputs from agencies.)